Navigation Links
Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
Date:7/22/2008

to help manage the potential risks that come with prolonged hyperglycemia," said Dr. Bergenstal. "The Adjust to Target trial demonstrated that basal-bolus insulin therapy may be an effective option for the many people with type 2 diabetes who are not achieving glycemic targets with their current insulin regimen."

About the Trial

Study participants were 28-71 years old, had type 2 diabetes for greater than or equal to 6 months and mean +/- SD A1C values of 8.1 +/- 0.9% (Simplified Algorithm) and 8.3 +/- 0.9% (Carb Counting Algorithm) at screening. They had taken greater than or equal to 2 insulin injections/day (36 percent on 2 injections, 64 percent on more than 2 injections) +/- metformin (one-third were on metformin), for greater than or equal to 3 months before study entry. Upon entry into the study, 37 percent were using Lantus(R) and at least one injection of a rapid-acting insulin analog, 36 percent were using a pre-mixed insulin and the remainder were on a combination of various other diabetes treatment regimens.

About Diabetes

Diabetes is a chronic, widespread condition in which the body does not produce or properly use insulin -- the hormone needed to transport glucose (sugar) from the blood into the cells of the body for energy. More than 230 million people worldwide are living with the disease and this number is expected to rise to a staggering 350 million within 20 years. It is estimated more than 20 million Americans have diabetes, including an estimated 6.2 million who remain undiagnosed.

At the same time, more than 40 percent of those diagnosed are not achieving the blood sugar control target of A1C <7 percent recommended by the American Diabetes Association (ADA). The A1C test measures average blood glucose levels over a two- to three-month period.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the live
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
4. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Newly Approved HIV Drug Shows Great Promise
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
9. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... -- E-QURE Corp (OTCQB: EQUR), today announced that Ron ... July 9, 2015. DATE: Thursday, July 9, 2015 ... This will be a live, interactive online event ... in real-time - both in the presentation hall as ... are not able to join the event live on ...
(Date:7/6/2015)... , July 6, 2015 Moerae ... developing novel therapeutics that target inflammation and fibrosis, ... , M.D., PhD, as Chief Medical Officer. ... clinical development strategy and programs, which include a ... inflammatory and fibrotic conditions.  Bill is an accomplished ...
(Date:7/6/2015)... July 6, 2015  Impax Laboratories, Inc. (NASDAQ: ... Ph.D. has resigned from the Company,s Board of Directors ... was a co-founder of Impax in 1995 and served ... October 2006 until April 2014. Logo - ... Impax,s President and Chief Executive Officer stated, "We wish ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5
... Osteotech, Inc. (Nasdaq: OSTE ), a leader ... healing, today reported financial results for the third quarter ... of 2009, our focus was on the release of ... FacetLinx(TM) Fusion Technology and Plexur M® Innovative Grafting," said ...
... Calif., Nov. 5 Renee Cobos, MD, a board ... University of California, Irvine, announced today that her patients ... system, which is approved for skin tightening and contouring, ... efficacy and improves patient comfort. , "Thermage has ...
Cached Medicine Technology:Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2
(Date:7/6/2015)... ... 2015 , ... Thanks to donations and a generous grant from the GAR ... Certification for hospice patients and adult day center participants. , The Music & Memory ... also to their families and volunteers. Music & Memory is a non-profit organization that ...
(Date:7/5/2015)... ... 2015 , ... World Patent Marketing, a vertically integrated manufacturer ... that effectively removes weeds without harming man and nature. , "The Landscaping Services ... Director of World Patent Marketing. "It is projected to grow at an annualized ...
(Date:7/4/2015)... York, NY (PRWEB) , ... July 04, 2015 , ... ... that 15% of chronic pain sufferers have pain located in the neck. Another 19% ... from the neck. Chiropractic literature suggests that 45% of American workers must ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... Friend opened registration for a new SEO training system called "Page One ... for organic traffic generation has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
Breaking Medicine News(10 mins):Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3
... Need for continuing, open dialogue remains , ... While health care reform legislation currently in Congress addresses many of the ... a number of issues including the public health insurance option and the ... "It is our objective to be a constructive partner with Congress and ...
... ... 1 August 2009 all doctors in training should be working a 48-hour week. Aimed at ... leaders are also seeing this move as a great opportunity, writes Robert Stiff MD Team24. ... (PRWeb UK) July ...
... , , , ... Inc. (PSH), a Los Angeles-based manufacturing and distribution corporation is proud to ... balm product division. Burner Balm, a natural lip balm that claims ... dietary, energy drink and lip balm arena. The product line is turning ...
... the heart , WEDNESDAY, July 22 (HealthDay News) -- ... one day be able to reverse the electrical problems in ... , Researchers grew "beating" cells with properties similar to the ... fat tissue of mice. They then injected them into rodents ...
... FT. MYERS, Fla., July 22 NeoGenomics, Inc. (NASD OTC ... quarter 2009 financial results on Tuesday, July 28, 2009. , ... call to discuss their Q2 09 results on July 28, 2009, at ... (201) 689-8049 (international) at least five minutes prior to the call. ...
... , AUSTIN, Texas, July 22 There are 125,000 ... solutions are the 125,000 NPs practicing in the United States today. For ... specialty care needs of their patients with the highest level of ... care provider, just as others may select MDs or DOs. , ...
Cached Medicine News:Health News:Michigan State Medical Society Weighs in on Proposed Federal Health Care Reform Legislation 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 3Health News:Burner Balm Gets International Attention 2Health News:Stem Cells Used for 'Biological Pacemaker' 2Health News:NeoGenomics Schedules Its Q2 2009 Earnings Release for July 28, 2009 2Health News:125,000 Solutions to the Primary Care Shortage - Nurse Practitioners (NPs) 2
... The ADVIA 120 Hematology System gets ... right the first time, with a ... systems. Results are more accurate, physicians ... more effective. The ADVIA 120 Hematology ...
The Advia 60 is designed to deliver powerful performance in a small package....
AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
... HmX offers three-dimensional VCS ... specificity and efficiency in ... reticulocyte analysis. With its ... dependability, HmX is an ...
Medicine Products: